QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.

Quotes for QuiaPEG Pharmaceuticals Holding AB

Right Now

+/-
-0.13
%
-3,90%
Latest
3.2
High
3.34
Low
3.2
Volume
12 318
Turnover (SEK)
39 818
Value (MSEK)
102,1

Board

CEO

  • Marcus Bosson

Chairman Of The Board

  • Steen Krøyer

Board

  • Christian Krog-Jensen
  • Johan von Kantzow
  • Jonas Jarvius
  • Lars Linzander
  • Marcus Bosson
  • Marek Kwiatkowski

Videos

Largest Owners

Name Capital % Votes % Date
Marek Kwiatkowski 23,56 23,56 2019-01-24
Nyenburgh Holding B.V. 23,09 23,09 2018-12-31
Marcus Bosson 9,63 9,63 2019-09-20
Avanza Pension 5,90 5,90 2019-09-30
Anders Vedin 3,55 3,55 2019-09-30
Stefan Persson 2,08 2,08 2019-09-30
Danica Pension 2,04 2,04 2019-09-30
Thomas Pollare 2,00 2,00 2019-09-30
Johan Thorell 1,91 1,91 2019-09-30
Formue Nord Markedsneutral A/S 1,77 1,77 2019-07-18
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream